Health Canada inspection
Shanghai Henlius Biopharmaceutical Co., Ltd.: Health Canada inspection of Aug 14, 2023
Health Canada · GMP · rating C
Key facts
| Establishment | Shanghai Henlius Biopharmaceutical Co., Ltd. |
|---|---|
| City | Xuhui District |
| Province | Shanghai |
| Country | China |
| Program | GMP |
| Start date | Aug 14, 2023 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.